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This letter was written because of the high incidence of acute hepatitis A in our hospital in this period of time. In December 2016 and January 2017, eight patients with acute hepatitis A were admitted to Gastroenterology Ward of Imam Hospital. Some of them had acute liver failure and fulminant hepatitis.

Fulminant hepatic failure is a rare complication of hepatitis A and it occurs in about 1% of the patients.^[@R1],[@R2]^ It was previously showed that the severity of hepatitis A was related to age.^[@R3]^ Acute hepatitis A in adulthood is more severe than in childhood.

In our country there is not routine vaccination program for hepatitis A virus. But because of improving the socioeconomic situation in Iran there are significant number of uninfected adult persons. In this circumstance, sometimes that we have crowded population like religious ritual, outbreak of hepatitis A can occur.^[@R4]-[@R6]^ Because of the older age of patients the prognosis of hepatitis become worsen.

The number of patients with acute hepatitis A in our ward surprisingly elevated in this 2-month period. Almost all of these patients participated in the crowded places. Other viral hepatitis and other causes of acute hepatitis were ruled out. The demographic data and also the lab data of the patients are shown in [table 1](#T1){ref-type="table"}.

###### Demographic and lab data of the patients with acute hepatitis A

  ----------------------------------- ------------- ------------- ------------- --------- ------------------- ----------- --------- --------
  **Patient Bilirubin (T-D) mg/dl**   **ALP u/l**   **ALT u/l**   **AST u/l**   **INR**   **Consciousness**   **Age**     **Sex**   
  1                                   6.7-3.7       450           291           150       1                   normal      35        male
  2                                   9.9-5.7       325           2788          1031      1.4                 normal      27        female
  3                                   13-7.8        435           3000          1141      3.6                 decreased   20        male
  4                                   8.7-5.6       275           4841          3531      1.4                 normal      24        male
  5                                   8.7-7.2       802           1694          947       1.2                 normal      26        female
  6                                   17.3-13.2     350           207           128       1                   normal      34        male
  7                                   17.5-8.5      435           1941          1245      1.9                 decreased   29        male
  8                                   16.3-10.2     533           1261          279       1.8                 normal      28        female
  ----------------------------------- ------------- ------------- ------------- --------- ------------------- ----------- --------- --------

ALP: Alkaline Phosphatase, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase

The main purpose of this letter is to investigate about the vaccination of hepatitis A. We think that the Ministry of Health and WHO should evaluate the incidence and also the severity of acute hepatitis A in the whole part of the country especially in adult patients. After evaluation of the cost effectiveness of hepatitis A vaccination revising the vaccination policy should be done especially for high risk adult persons. There are some cost effectiveness studies in the medical literatures.^[@R7]^ These studies have good guide for this evaluation. An important group of these high risk people for hepatitis A is the pilgrims of Karbala in Arbaeen of Imam Hussein, because many people participate in this ritual from many nationalities.
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